These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Timely addition of insulin to oral therapy for type 2 diabetes. Riddle MC Diabetes Care; 2002 Feb; 25(2):395-6. PubMed ID: 11815517 [No Abstract] [Full Text] [Related]
10. Combination therapy for NIDDM: has its time arrived? Menke J S D J Med; 1995 Aug; 48(8):246-7. PubMed ID: 7569874 [No Abstract] [Full Text] [Related]
11. [Proper selection and practical administration of sulphonylurea agents to diabetics]. Kurahachi H Nihon Rinsho; 2002 Sep; 60 Suppl 9():346-50. PubMed ID: 12387016 [No Abstract] [Full Text] [Related]
15. [Combination therapy of oral hypoglycemic agents which enhance the efficacy of insulin therapy]. Hirose T Nihon Rinsho; 2012 May; 70 Suppl 3():669-77. PubMed ID: 22768596 [No Abstract] [Full Text] [Related]
16. [Fear of the injection must not be an argument. Every second type 2 diabetic patient needs insulin]. MMW Fortschr Med; 2002 Dec; 144(49):60. PubMed ID: 12577748 [No Abstract] [Full Text] [Related]
17. Pareto's law and sulfonylureas. Peiris AN; Micklewright M; Gangadharan V South Med J; 2007 Nov; 100(11):1072-3. PubMed ID: 17984734 [No Abstract] [Full Text] [Related]
18. The UK Prospective Diabetes Study. Kerner W Lancet; 1998 Dec; 352(9144):1934. PubMed ID: 9863811 [No Abstract] [Full Text] [Related]
19. The UK Prospective Diabetes Study. Evans M Lancet; 1998 Dec; 352(9144):1932-3; author reply 1934. PubMed ID: 9863807 [No Abstract] [Full Text] [Related]
20. The UK Prospective Diabetes Study. Bailey CJ; Grant PJ Lancet; 1998 Dec; 352(9144):1932; author reply 1934. PubMed ID: 9863806 [No Abstract] [Full Text] [Related] [Next] [New Search]